(19)
(11) EP 4 430 403 A1

(12)

(43) Date of publication:
18.09.2024 Bulletin 2024/38

(21) Application number: 22817878.6

(22) Date of filing: 10.11.2022
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/574; G01N 33/57492
(86) International application number:
PCT/EP2022/081379
(87) International publication number:
WO 2023/083924 (19.05.2023 Gazette 2023/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 10.11.2021 EP 21306577

(71) Applicants:
  • Institut Gustave-Roussy
    94800 Villejuif (FR)
  • Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)
  • Université Paris-Saclay
    91190 Gif-sur-Yvette (FR)

(72) Inventors:
  • TSELIKAS, Lambros
    94220 Charenton le Pont (FR)
  • DANLOS, François-Xavier
    93100 Montreuil (FR)
  • BREDEL, Delphine
    94800 Villejuif (FR)
  • SUSINI, Sandrine
    75015 Paris (FR)
  • BONVALET, Mélodie
    91370 Verrieres-le-Buisson (FR)
  • MOURAUD, Séverine
    92140 Clamart (FR)
  • ROBERT, Caroline
    92260 Fontenay aux Roses (FR)
  • MARABELLE, Aurélien
    92330 Sceaux (FR)

(74) Representative: Cabinet Becker et Associés 
25, rue Louis le Grand
75002 Paris
75002 Paris (FR)

   


(54) PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY